comparemela.com
Home
Live Updates
Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures : comparemela.com
Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures
/PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that the U.S. Food and Drug Administration...
Related Keywords
Alexander Sah
,
Ira Duarte
,
Drug Administration
,
Exchange Commission
,
Nasdaq
,
Sah Orthopaedic Associates
,
Heron Therapeutics Inc
,
European Union
,
Heron Therapeutics
,
New Drug Application
,
Vial Access Needle
,
Craig Collard
,
Chief Executive Officer
,
Bill Forbes
,
Executive Vice President
,
Chief Development Officer
,
Sah Orthopaedic
,
Safety Information
,
Prescribing Information
,
European Commission
,
United Kingdom Regulatory Authority
,
Private Securities Litigation Reform Act
,
Boxed Warning
,
Media Contact
,
Vice President
,
Chief Financial
,
Nc
,
comparemela.com © 2020. All Rights Reserved.